EU Panel Starts Safety Review of Ingenol Mebutate (Picato) Gel

Share this post

A European Medicines Agency safety committee is reviewing data on cases of skin cancer in patients who use topical ingenol mebutate to treat actinic keratosis.
News Alerts

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Share this post

Be the first to comment

Leave a Reply